Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation. - Wikidata - awgldk - TriplyDB

Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation.

Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation.

http://www.wikidata.org/entity/Q37276726

about

Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases New insights into the biology of tissue factor pathway inhibitor Single nucleotide polymorphisms in an intergenic chromosome 2q region associated with tissue factor pathway inhibitor plasma levels and venous thromboembolism.Biology of tissue factor pathway inhibitor.Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor Translation of human tissue factor pathway inhibitor-β mRNA is controlled by alternative splicing within the 5' untranslated region.Causality relationships between coagulation factors in type 2 diabetes mellitus: path analysis approach Platelets contain tissue factor pathway inhibitor-2 derived from megakaryocytes and inhibits fibrinolysis.Polyphosphate: a new player in the field of hemostasis 2013 scientific sessions Sol Sherry distinguished lecture in thrombosis: polyphosphate: a novel modulator of hemostasis and thrombosis.A balance between TFPI and thrombin-mediated platelet activation is required for murine embryonic development Polyphosphate as modulator of hemostasis, thrombosis, and inflammation Platelet-Derived Short-Chain Polyphosphates Enhance the Inactivation of Tissue Factor Pathway Inhibitor by Activated Coagulation Factor XI.Tissue Factor Pathway Inhibitor: Multiple Anticoagulant Activities for a Single Protein.Targeting TFPI for hemophilia treatment.Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S.Leveraging cell type specific regulatory regions to detect SNPs associated with tissue factor pathway inhibitor plasma levels.Endogenous tissue factor pathway inhibitor in vascular smooth muscle cells inhibits arterial thrombosis.Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders.Rethinking events in the haemostatic process: role of factor V and TFPI.Blocking inhibition of prothrombinase by tissue factor pathway inhibitor alpha: a procoagulant property of heparins.The effect of corn trypsin inhibitor, anti-tissue factor pathway inhibitor antibodies and phospholipids on microvesicle-associated thrombin generation in patients with pancreatic cancer and healthy controls.Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation.Engineering a new generation of hemostatic agents: highlights of the Scientific Session on Hemostasis at the 2013 meeting of the American Society of Hematology.The C-terminus of tissue factor pathway inhibitor-α inhibits factor V activation by protecting the Arg1545 cleavage site.Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal Contraception.Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex.Significant genetic association of a functional TFPI variant with circulating fibrinogen levels and coronary artery disease.Novel therapies and current clinical progress in hemophilia A.Suppressive Role of Tissue Factor Pathway Inhibitor-α in Platelet-Dependent Fibrin Formation under Flow Is Restricted to Low Procoagulant Strength.Polyphosphate accelerates factor V activation by factor XIa.Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab.Correlates of plasma and platelet tissue factor pathway inhibitor, factor V, and Protein S.Advances in Clinical and Basic Science of Coagulation: Illustrated abstracts of the 9th Chapel Hill Symposium on Hemostasis

P2860

Q26828872-8290AB12-2AAD-4A9C-AD1A-73FA81699F4C Q26865048-22676D1D-EF7F-45A5-9337-1DE4B4634C3C Q30275601-4A3A1AD3-0593-4841-A98B-604034C0EC41 Q33585249-1866A212-0EA6-4EB3-B38D-AC54F1084B41 Q33648222-1176F63B-086B-4C8C-BAC3-FE5C2BB3F7F7 Q33706688-387FB20F-469D-4FD5-AEBC-C7E3A70FEE47 Q34451089-D885D6AD-8B9E-48C7-A3EF-210635C2DD8E Q34467715-455A2C04-C4B7-4167-A13E-40BE7A9B05C0 Q35556300-A4A4D7F8-608B-45C4-A82D-8F904891A270 Q35637441-21280FAE-9E38-4A0B-A9B0-1ED284BC73D9 Q35784515-9BE23A6B-B8BB-4F23-8A0C-7ACCA66FD1BF Q35835056-78AE587A-B1E7-432E-BF71-77F2DE94966E Q36169665-54C98FA3-D5D3-42A8-B37A-D45CFE60AB62 Q36403196-5CC8C331-FE45-41BE-8416-5E1DE0ACA804 Q37108074-537BBCC9-6D77-468D-A13D-89C4827A9D3E Q38663583-5F44004F-2369-4370-95FC-88E7CD4846F8 Q38728512-EF702284-326D-4F33-BCC5-27E4B78F1071 Q38760481-BB2BF2F9-80B4-49B9-9D6A-E60BC131B14C Q38830523-7877A3AD-6040-4714-A599-6B6438BACE71 Q38894147-7274C2BF-D47D-43C7-8AA7-4B0E886DA20D Q39683706-EEEB015A-07AA-4C3E-AA92-EE4010B390B9 Q41071373-E9B599D2-DCD8-4187-93C4-42B2F379050D Q41936652-5B72F27C-C1DC-4C1B-9D67-1CE33D16F766 Q45863501-EC2D3444-8CAA-4F5D-9473-90FACBB681F0 Q46466521-B1D182C0-711F-4040-B8F1-28279C2973BF Q47447917-E326C26B-0DD0-45FB-B3FD-310681C9D0F1 Q47900623-018078A4-6862-4FD2-959A-40B857D28CBF Q47999144-F94A0907-937C-42EC-BAF8-99D0E84BBE87 Q49745450-90F67FC0-2FC1-418E-8684-AAF83A8E0EE5 Q49922306-4A5C7B54-AAF3-4C50-A741-87F8E6375290 Q53721304-E23D6A4A-7B82-4E2B-A5EC-CBBE30063834 Q55346403-6BBFCA92-1BDA-4E89-B562-BD3920FCED68 Q55447752-C412084F-C380-4262-AA94-9428E62B0101 Q58895615-F870F520-D29C-4217-AC82-1E6FA3707361

P2860

Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation.

http://www.wikidata.org/entity/Q37276726

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Tissue factor pathway inhibito ...... itiation of blood coagulation.

@en

Tissue factor pathway inhibito ...... itiation of blood coagulation.

@nl

type

label

Tissue factor pathway inhibito ...... itiation of blood coagulation.

@en

Tissue factor pathway inhibito ...... itiation of blood coagulation.

@nl

prefLabel

Tissue factor pathway inhibito ...... itiation of blood coagulation.

@en

Tissue factor pathway inhibito ...... itiation of blood coagulation.

@nl

P1433

Q37276726-254AC8D5-C5ED-407C-ACCB-4403C2F6EE9E

P1476

Q37276726-CA9C2D69-FB6F-43A9-B255-02AD82D82D6F

P2093

Q37276726-59467E9F-CA2D-4714-86B8-B897D956B7FF

Q37276726-787B9F78-2B2F-4D9D-8C08-224D0985C32D

Q37276726-7B1023A7-6A7A-428A-B73D-57706BD1299F

Q37276726-823A4AFD-F31F-45C0-977D-676F94DC2514

Q37276726-BF1931C9-2AD4-415A-84FC-75318A25EAB7

Q37276726-C5A67CD0-5AA1-41F1-8324-AC8F62641D97

P2860

Q37276726-01480E10-A8DF-4799-A1FF-9A3666ED73F7

Q37276726-038C3D9D-FF7C-4862-A363-E1D747ED3B19

Q37276726-0B2E585C-D5B7-4019-9403-C1AFE75A5CC2

Q37276726-139F30C6-BC1A-4996-93B2-E5609ACD17DD

Q37276726-13BC5AD6-C486-47D1-8E6E-AB6EBF629A59

Q37276726-1B1F470E-EBC6-4469-8B76-D80E65D77716

Q37276726-2E09068D-1527-45A5-987E-E546E0F99B3E

Q37276726-2FEB1559-BBB7-4DE6-82EA-7C5E44D2A72E

Q37276726-336EB285-A03F-46C1-9989-E8BB02F3D8F2

Q37276726-37546C41-CBDE-47DF-9001-C710F91412AF

P304

Q37276726-34A19688-6039-4230-BEDA-7E2056EA5063

P31

Q37276726-7F551F0C-E99D-4D8C-AFBE-8A4D9B2D7E71

P356

Q37276726-8F0B5C41-CDF5-40F8-B5DF-FAF9ABDA7A46

P407

Q37276726-F5424737-2111-44A6-9329-B0DD612E0729

P433

Q37276726-9239E5B0-C67A-4C63-BA2C-96F6F4A8C2A8

P478

Q37276726-BF6CFD96-1C32-41D1-8054-AC0F466CB671

P577

Q37276726-6433AE78-5A1A-4FD8-9728-2F107DDEE433

P5875

Q37276726-2F593323-EBD6-4649-9920-661D7C10B888

P698

Q37276726-15C493BD-044B-427C-B0B2-13834F5FDAF0

P932

Q37276726-BBB25C6E-38FC-4471-8E30-9EE545ECF823

P356

PNAS.1310444110

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Tissue factor pathway inhibito ...... itiation of blood coagulation.

@en

P2093

Alan E Mast

http://www.w3.org/2001/XMLSchema#string

Jeremy P Wood

http://www.w3.org/2001/XMLSchema#string

Matthew W Bunce

http://www.w3.org/2001/XMLSchema#string

Paula B Tracy

http://www.w3.org/2001/XMLSchema#string

Rodney M Camire

http://www.w3.org/2001/XMLSchema#string

Susan A Maroney

http://www.w3.org/2001/XMLSchema#string

P2860

Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model

Crystal structure of the prothrombinase complex from the venom of Pseudonaja textilis

Clustal W and Clustal X version 2.0

Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor

Heterogeneity of plasma tissue factor pathway inhibitor

Characterization of the protein Z-dependent protease inhibitor.

The Kunitz-3 domain of TFPI-alpha is required for protein S-dependent enhancement of factor Xa inhibition

Polyphosphate modulates blood coagulation and fibrinolysis.

Human platelet dense granules contain polyphosphate and are similar to acidocalcisomes of bacteria and unicellular eukaryotes.

Polyphosphate exerts differential effects on blood clotting, depending on polymer size.

P304

17838-17843

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1310444110

http://www.w3.org/2001/XMLSchema#string

P407

P433

44

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257815272

http://www.w3.org/2001/XMLSchema#string

P698

24127605

http://www.w3.org/2001/XMLSchema#string

P932

3816478

http://www.w3.org/2001/XMLSchema#string